News
1d
Zacks.com on MSNMRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 ShotsThough the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer ...
We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...
BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer Inc. (NYSE:PFE) and kept the price target the same at ...
The stock's fall snapped a four-day winning streak.
Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...
13d
24/7 Wall St. on MSNPfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
If you see a stock that pays 6% in dividends, you might assume it's too risky -- but that's not always the case. In some ...
Pfizer also announced a hefty total dividend of Rs 165 per equity share for FY25. This includes a final dividend of Rs 35 per ...
Pfizer share price gained 13% in the intraday trades on Tuesday post Q4 Results, dividend announcement and despite stock ...
3SBio's shares surged 32% to 19.18 Hong Kong dollars, equivalent to US$2.45, on Tuesday after the Chinese company said it would receive an upfront payment of US$1.25 billion and potential milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results